We are live on
!
Find out more
SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
206 hedge funds and large institutions have $2.39B invested in Sage Therapeutics in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 74 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
232% more call options, than puts
Call options by funds: $22M | Put options by funds: $6.63M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
41% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 22
17% more capital invested
Capital invested by funds: $2.04B → $2.39B (+$348M)
3% more funds holding
Funds holding: 200 → 206 (+6)
1.04% less ownership
Funds ownership: 87.86% → 86.82% (-1%)
23% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 74
Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3.31%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
31
Increased
57
Reduced
74
Closed
22
Calls
$22M
Puts
$6.63M
Net Calls
+$15.4M
Net Calls Change
-$1.47M
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$26.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.28M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.93M |
| 5 |
Morgan Stanley
New York
|
+$6.22M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$32.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$31.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.28M |
| 4 |
State Street
Boston,
Massachusetts
|
-$8.68M |
| 5 |
Goldman Sachs
New York
|
-$6.32M |
